← Leaderboards
Christopher J Cooper
University Of Toledo Health Sci Campus
$20,111,796
Attributed
$21,763,801
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $4.4M · FY2005–13$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
Funding mix
By agency
NIH$21,763,801 · 2
By mechanism
U01$19,285,793 · 1
R44$2,478,008 · 1
Top collaborators
- Vincent J Pompili3 shared
- Ramasamy Sakthivel3 shared
Most similar at University Of Toledo Health Sci Campus
Same institution · by research overlap
- Thyagarajan Subramanian$6,655,609
- Jiang Tian$1,841,416
- William A Maltese$4,759,505
Others in their field
Top investigators on “Clinical Trials”
- Lawrence Corey · Fred Hutchinson Cancer Center$824,102,536
- Sonia M Thomas · Research Triangle Institute$700,865,642
- David Heimbrook · Leidos Biomedical Research, Inc.$622,583,125
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$542,008,718
- Bambra Strokes · Ppd Development Lp$526,656,217
- Judith S. Currier · University Of California Los Angeles$504,273,077
Research focus
Clinical TrialsDiabetes MellitusBlood VesselsWomanClinically RelevantGenderStrokeMyocardial InfarctionCost EffectivenessQuality Of LifeCigarette SmokingCategoriesAntihypertensive AgentsCharacteristicsCaringCessation Of LifeClinically SignificantBiochemistryBlood PressureAdverse EffectsBlood Pressure RegulationAmericanCardiovascular SystemCaliber
Grant awards (13)
CORAL: Clinical Coordinating Center$1,137,594
U01 · FY2013 · HL · contact PI
CORAL: Clinical Coordinating Center$1,592,393
U01 · FY2012 · HL · contact PI
CORAL: Clinical Coordinating Center$1,704,579
U01 · FY2011 · HL · contact PI
Therapeutic Potential of Ex vivo expanded Human Cord Blood derived CD133+ cells i$586,833
R44 · FY2011 · HL · contact PI
CORAL: Clinical Coordinating Center$2,753,284
U01 · FY2010 · HL · contact PI
Therapeutic Potential of Ex vivo expanded Human Cord Blood derived CD133+ cells i$1,609,381
R44 · FY2010 · HL · contact PI
CORAL: Clinical Coordinating Center$1,169,702
U01 · FY2008 · HL · contact PI
Therapeutic Potential of Ex vivo expanded Human Cord Blood derived CD133+ cells i$281,794
R44 · FY2008 · HL · contact PI
CORAL: Clinical Coordinating Center$47,820
U01 · FY2008 · HL · contact PI
CORAL: Clinical Coordinating Center$1,948,320
U01 · FY2007 · HL · contact PI
CORAL: Clinical Coordinating Center$3,214,285
U01 · FY2006 · HL · contact PI
CORAL: Clinical Coordinating Center$3,649,649
U01 · FY2005 · HL
CORAL: Clinical Coordinating Center$2,068,167
U01 · FY2004 · HL